Ketamine Intravenous Therapy (KIT)

Ketamine Intravenous Therapy (KIT)

A study examining Ketamine Intravenous Therapy (KIT) for depression reported promising outcomes. From 2016-2020, over 9,000 patients from across the U.S. received KIT. Using the PHQ-9 scale, 53.6% of the 537 patients assessed showed a significant response to KIT 14-31 days post-induction, with a 50% or more reduction in PHQ-9 scores. Additionally, 28.9% achieved remission, marked by a PHQ-9 score below 5. The treatment’s impact was profound with an effect size of d=1.5.

Positive outcomes were also noted for patients with suicidal thoughts, with 73% showing a decrease post-treatment. However, 8.4% had increased depressive symptoms, while 6.0% had heightened suicidal ideation post-induction.

The KIT response was consistent across different depression severities, but those with more severe symptoms showed slightly greater PHQ-9 score reductions. The odds of achieving remission were inversely linked to depression severity. Importantly, those responding to KIT had high chances of sustained improvement—80% at 4 weeks and 60% at 8 weeks post-induction.

Ketamine Intravenous Therapy (KIT) is an emerging and promising treatment for depression. Recent studies have underscored its effectiveness, and at Luvita, we’ve observed a response rate exceeding 80%.

Understanding the science and the nuances behind a treatment is crucial for making informed healthcare decisions. KIT works differently than traditional antidepressants, targeting specific pathways in the brain that may offer relief in cases resistant to other treatments.

For those interested in exploring evidence-based treatments for depression, we recommend familiarizing yourself with KIT. Luvita is not only a provider of this innovative treatment but also an educational resource. Our primary objective is to ensure patients are well-informed, comfortable, and confident in their treatment choices.

Curious about how KIT could potentially benefit you or a loved one? Consider booking a free consultation with us to learn more: Luvita

Share Post :

Request An Appointment

Conditions We Treat

(406)-213-7862

Have a question or need to schedule an appointment? Give us a call now.

Related Post

How To Prevent Seasonal Depression - Luvita in Helena, MT
Seasonal Depression

How To Prevent Seasonal Depression

Seasonal depression, also known as seasonal affective disorder (SAD), is a type of depression that occurs at the same time each year, usually during fall

Read More »
Which PTSD Treatment Options Are Best? - Luvita in Helena MT
PTSD

Which PTSD Treatment Options Are Best?

Post-traumatic stress disorder (PTSD) is a complex mental health condition that affects millions of individuals worldwide. Understanding the various treatment options available is crucial in

Read More »
Identifying Common OCD Triggers - Luvita in Helena, MT
OCD

Identifying Common OCD Triggers

Obsessive-compulsive disorder (OCD) is a condition that affects millions of people worldwide. It involves the presence of unwanted and intrusive thoughts, as well as repetitive

Read More »
Medications for Substance Use Disorders - Luvita Helena MT
Medication Management Services

Medications for Substance Use Disorders

In recent years, substance use disorders have become a growing concern worldwide. These disorders, characterized by the persistent use of substances despite negative consequences, can

Read More »
What is Medication Management? - Luvita in Helena, MT
Medication Management Services

What is Medication Management?

Medication management is a critical aspect of healthcare that focuses on the safe and effective use of medications to optimize patient outcomes. It involves a

Read More »
Call Now
Consultation